Fig. 2: Attenuation of early periportal hepatocyte proliferation induces a transient reduction in liver mass.
From: Periportal hepatocyte proliferation at midgestation governs maternal glucose homeostasis in mice
a Experimental design for AAV8-p21 injection. b Liver mass (top graph) and liver-to-body mass ratio (bottom graph) of mice injected with AAV8-null or AAV8-p21 at the indicated time points (null NP→dpc8, n = 4 mice; p21 NP→dpc8, n = 8 mice; null dpc10→dpc16, n = 6 mice; p21 dpc10→dpc16, n = 4 mice; null NP→dpc16, n = 6 mice; p21 NP→dpc16, n = 6 mice). Data were compared using the two-tailed Studentʹs t-test. Data are mean ± s.e.m.
